“The Role of Immunometabolic Dysregulation in Obesity-Associated Cardiovascular Risk: A Narrative Review”, J Evid Based Med Res, vol. 2, no. 1, Mar. 2026, doi: 10.66687/jebmr.2.1.2026.29.